Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1M Sell
2,846
-25
-0.9% -$8.91K 0.43% 47
2025
Q4
$940K Sell
2,871
-24
-0.8% -$7.61K 0.39% 48
2025
Q3
$817K Sell
2,895
-16
-0.5% -$4.64K 0.35% 50
2025
Q2
$813K Sell
2,911
-123
-4% -$34.8K 0.36% 52
2025
Q1
$945K Sell
3,034
-61
-2% -$18K 0.45% 46
2024
Q4
$807K Sell
3,095
-2
-0.1% -$593 0.38% 52
2024
Q3
$998K Hold
3,097
0.46% 49
2024
Q2
$968K Sell
3,097
-37
-1% -$10.9K 0.48% 46
2024
Q1
$891K Sell
3,134
-22
-0.7% -$6.44K 0.44% 49
2023
Q4
$909K Sell
3,156
-110
-3% -$30K 0.5% 49
2023
Q3
$770K Sell
3,266
-48
-1% -$12K 0.47% 52
2023
Q2
$736K Buy
3,314
+2
+0.1% +$464 0.43% 52
2023
Q1
$801K Sell
3,312
-22
-0.7% -$5.4K 0.49% 51
2022
Q4
$876K Buy
3,334
+2
+0.1% +$536 0.56% 50
2022
Q3
$751K Sell
3,332
-29
-0.9% -$7.03K 0.54% 50
2022
Q2
$818K Buy
3,361
+26
+0.8% +$6.37K 0.55% 45
2022
Q1
$806K Buy
3,335
+2
+0.1% +$460 0.47% 50
2021
Q4
$750K Sell
3,333
-150
-4% -$31.7K 0.44% 52
2021
Q3
$741K Buy
3,483
+1
+0% +$230 0.46% 53
2021
Q2
$849K Sell
3,482
-139
-4% -$34.2K 0.51% 51
2021
Q1
$901K Sell
3,621
-89
-2% -$21.2K 0.59% 46
2020
Q4
$853K Sell
3,710
-101
-3% -$23.3K 0.58% 44
2020
Q3
$969K Buy
3,811
+1,168
+44% +$289K 0.74% 36
2020
Q2
$623K Hold
2,643
0.54% 46
2020
Q1
$536K Buy
2,643
+1,298
+97% +$284K 0.56% 45
2019
Q4
$324K Buy
+1,345
New +$296K 0.32% 47

Other funds holding AMGN

Pavion Blue Capital's AMGN Position: Q1 2026 in Review

Pavion Blue Capital reduced its Amgen (AMGN) stake by 0.87% in Q1 2026, selling an estimated $8.91K and leaving 2,846 shares worth $1M. The position accounts for 0.43% of the portfolio, ranked #47.

Pavion Blue Capital first reported a position in AMGN in Q4 2019 and has held it in 26 quarters since. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Pavion Blue Capital held 2,846 shares of Amgen worth $1M as of Q1 2026.
  • Pavion Blue Capital sold 25 Amgen shares in Q1 2026, an estimated $8.91K.
  • Amgen made up 0.43% of Pavion Blue Capital's portfolio in Q1 2026, its #47 holding.
  • Pavion Blue Capital first reported a position in Amgen in Q4 2019 and has held it in 26 quarters since.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Pavion Blue Capital's 13F filing for Q1 2026, filed 6 May 2026.